ClinicalTrialsFinder
RecruitingNCT07611838

Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction

Multi-Omics Data-Derived Inflammatory Phenotype for ABPA Recurrence Risk Prediction: A Multicenter Study

Sponsor

Qianfoshan Hospital

Enrollment

300 participants

Start Date

Jan 1, 2021

Study Type

OBSERVATIONAL

Conditions

RelapseMulticenter StudyMulti-omicsMachine LearningAllergic Bronchopulmonary Aspergillosis (ABPA)

Summary

To develop and externally validate a machine learning model for predicting the 1-year risk of relapse in patients with stable ABPA, and to further evaluate its value in risk stratification and clinical decision-making.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with allergic bronchopulmonary aspergillosis (abpa), machine learning, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China, Jinan, Shandong 250014

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07611838

Related Trials

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT063470681 location

SEPSIS EARLY WARNING: NEWS2 VS MACHINE LEARNING

NCT077344801 location

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

NCT059275581 location

ML-Based ABPA Recurrence Prediction and Clinical Utility

NCT077148631 location

Fungal Status and Prognosis in ABPA

NCT076903451 location